Letrozole
| Use attributes for filter ! | |
| Molar mass | 285. 303 g/mol |
|---|---|
| CAS ID | 112809-51-5 |
| Formula | C17H11N5 |
| Excretion | Kidneys |
| Drug class | Aromatase inhibitor; Antiestrogen |
| Trade name | Femara, others |
| Elimination half-life | 2 days |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951108 |
About Letrozole
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor which is used in the treatment of hormonally-responsive breast cancer after surgery. It was patented in 1986 and approved for medical use in 1996.